BXR-17663-46360
3 vaccinations
2 coded responses
15 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 481 / MI
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Moderna
-
2021-02-03
Registered in v-safe
- 2021-02-03
- 2021-02-05
-
2021-02-12
Dose 2 — Moderna
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-21
- 2021-03-12
- 2021-08-13
-
2021-10-22
Dose 3 — Moderna
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-10-25
- 2021-10-27
-
2021-12-08
Survey response — day 42, dose 3MedDRA: Pre-eclampsia, Premature delivery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Premature birth, pre-eclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2021-12-08
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-12-09
-
2022-01-21
Survey response — 3 months, dose 3MedDRA: Pre-eclampsia, Premature delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Preterm birth, pre eclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-01-24
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 10 — day 42, dose 3
Symptoms: Premature birth, pre-eclampsia
Release 11 — 3 months, dose 3
Symptoms: Preterm birth, pre eclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Premature delivery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release